Zheng JP, Wen FQ, Bai CX, Wan HY, Kang J, Chen P, Yao WZ, Ma LJ, Li X, Raiteri L, et al
GLP-1 medications, also called GLP-1 agonists, mimic the effects of the bodys natural GLP-1 hormone
Other Resources for Costochondritis of the Thoracic Spine References: Schumann JA, Parente JJ
Management of risk factors a) Hypertension (Figure S4) Hypertension is a major modifiable CVD risk factor, and its concurrent existence with T2DM leads to an additive and sometimes synergetic effect on CVD risk
Saxenda Currently in shortage In shortage 6 mg/1 mL In shortage
Hypoglycemia risk Although the risk of hypoglycemia with these medications is generally low, combining them could potentially increase this risk, especially in patients also taking insulin or sulfonylureas